IRB Barcelona is an international biomedical research center devoted to curing cancer and other diseases linked to aging. With a founding date of 2005, the institution holds a significant position in the field of biomedical research. Their slogan, "International biomedical #research center devoted to curing #cancer and other diseases linked to #aging. CERCA-BIST.", reflects their strong commitment to their cause. The organization's research purpose is aimed at addressing fundamental biological questions to decipher the development of diseases and find innovative ways to diagnose, prevent, and treat them. Comprising more than 500 scientists and support staff from 41 nationalities, IRB Barcelona is organized around three major research challenges: Cancer Science, Aging and Metabolism, and Mechanisms of Disease. It is worth noting that the Institute has been recognized for its excellence, having received the "Severo Ochoa Centre of Excellence" award from the Spanish Ministry of Science and Innovation four consecutive times, making it a significant player in the industry. Additionally, IRB Barcelona has already established six active spin-off companies, including Accure Therapeutics, Inbiomotion, Nostrum Biodiscovery, Ona Therapeutics, Gate2Brain, and Nuage Therapeutics, reflecting the institution's intent to translate their research results into tangible benefits for patients. Situated at the Barcelona Science Park (PCB), IRB Barcelona aligns with the vision of creating a society free of diseases and contributes significantly to the advancement of biomedical research.
There is no investment information
No recent news or press coverage available for IRB Barcelona.